The Aplio Platnium Series CV (cardiovascular) ultrasound systems from Toshiba America Medical Systems offer a comprehensive suite of dedicated technology for cardiac diagnosis. The series, including the Aplio 500 Platinum CV and Aplio 300 Platinum CV, feature 2-D Wall Motion Tracking, spectral and color Doppler, and Toshiba’s latest suite of guidance and workflow technologies.

Toshiba’s Aquilion One Vision Edition computed tomography (CT) system is capable of aiding clinicians in diagnosing patients presenting with chest pain. The system was showcased at the American College of Cardiology (ACC) annual meeting in San Diego, March 14-16.

BioImage study, Mount Sinai, cardiovascular disease, ultrasound, CT, detection

Adding two non-invasive imaging tests to traditional cardiovascular disease risk factor assessment more precisely predicts a healthy patient’s future risk of heart attack, stroke, or premature death, according to a new study. The study was led by Icahn School of Medicine at Mount Sinai and published in the March 24 edition of the Journal of the American College of Cardiology (JACC).

American College of Cardiology (ACC) President Kim Allan Williams Sr., M.D., FACC, issued the following statement in response to the Senate Health, Education, Labor and Pensions Committee on “America’s Health IT Transformation: Translating the Promise of Electronic Health Records into Better Care":

AliveCor Inc. announced the launch of a cloud-based electrocardiogram (ECG) analytics program with Preventice Solutions. Using AliveCor’s proprietary algorithms in this pilot program, Preventice Solutions intends to improve its internal workflow by reading the most critical ECGs first.

catheter ablation, Afib, Amiodarone, Luigi Di Biase, ACC, heart failure

Patients with heart failure and atrial fibrillation were less likely to experience death, hospitalization or recurrent Afib with catheter ablation than with a heart rhythm-regulating drug, according to a new study. Catheter ablation was most successful in procedures where ablation was required in other areas in addition to the pulmonary vein. The study was presented at the American College of Cardiology’s 64th Annual Scientific Session.

BioTelemetry Inc. has reached a settlement agreement with the U.S. Department of Justice related to allegations that BioTelemetry encouraged physicians to use two non-specified diagnosis codes to ensure coverage of mobile cardiac telemetry. Per the agreement, BioTelemetry will pay $6.4 million to the Department of Justice, which was reflected in the Company's 2014 financial statements.

The Society for Cardiovascular Angiography and Interventions (SCAI) 2015 Scientific Sessions will take place May 6-9 in San Diego, California. SCAI 2015 will deliver updates affecting the invasive/interventional cardiovascular field, including late-breaking clinical trials; keynote addresses; and practice-relevant education for diagnosing and treating patients with congenital, coronary, peripheral and structural heart disease.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now